Neopterin levels and dexamethasone suppression test in obsessive-compulsive disorder

Psychiatry Research

Volumn 151, Issue 3, 2007, Pages 265-270

  Kuloǧlu, Murat ^a   Atmaca, Murad ^b   Önal, Süleyman ^b   Geçici, Ömer ^c   Bulut, Vedat ^b   Tezcan, Ertan ^b  

^a ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b FIRAT UNIVERSITY   (Turkey)

^c AFYON KOCATEPE UNIVERSITY   (Turkey)

Author keywords

Depression; DST; Neopterin; OCD

Indexed keywords

DEXAMETHASONE; HYDROCORTISONE; NEOPTERIN;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; MALE; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL;

ADOLESCENT; ADULT; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; DEXAMETHASONE; DYSTHYMIC DISORDER; FEMALE; HUMANS; HYDROCORTISONE; IMMUNITY, CELLULAR; MALE; MIDDLE AGED; NEOPTERIN; OBSESSIVE-COMPULSIVE DISORDER; REFERENCE VALUES;

EID: 34249700836     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2002.04.001     Document Type: Article

References (26)

1. Besedovsky H., del Rey A., Sorkin E., and Dinarello C. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science 233 (1986) 652-654
2. Brambilla F., Perna G., Bellodi L., Arancio C., Bertani A., Perini G., Carraro C., and Gava F. Plasma interleukin-1 beta and tumor necrosis factor concentrations in obsessive-compulsive disorders. Biological Psychiatry 42 11 (1997) 976-981
3. Carroll B.J., Feinberg M., Greden J.F., Tarika J., Albala A.A., Haskett R.F., James N.M., Kronfol Z., Lohr N., Steiner M., de Vigne J.P., and Young E. A specific laboratory test for the diagnosis of melancholia. Archives of General Psychiatry 38 (1981) 15-22
4. Catapano F., Monteleone P., Maj M., and Kemali D. Dexamethasone suppression test in patients with primary obsessive-compulsive disorder and in healthy controls. Neuropsychobiology 23 (1990) 53-56
5. Checkley S.A. Biological markers in depression. In: Granville-Grossman K. (Ed). Recent Advances in Psychiatry. 3rd ed (1985), Churchill Livingstone, Edinburgh 955-957
6. Coryell W., Noyes R.J., and Schlechter J. The significance of HPA axis disturbance in panic disorder. Biological Psychiatry 25 (1989) 989-1002
7. Cottraux J.A., Bouvard M., and Claustrat B. Abnormal dexamethasone suppression test in primary obsessive compulsive patients: a confirmatory report. Psychiatry Research 13 (1984) 157-165
8. Crabtree G.R., Gillis S., Smith K.A., and Munck A. Glucocorticoids and immune responses. Arthritis and Rheumatism 22 (1979) 1246
9. Gehris T.L., Kathol R.G., Black D.W., and Noyes Jr. R. Urinary free cortisol levels in obsessive-compulsive disorder. Psychiatry Research 32 (1990) 151-158
10. Goodman W.K., Price L.H., and Rasmussen S.A. The Yale-Brown Obsessive Compulsive Scale. Archives of General Psychiatry 46 (1989) 1006-1016
11. Goodwin D.W., Guze S.B., and Robins E. Follow-up studies in obsessional neurosis. Archives of General Psychiatry 20 (1969) 182-187
12. Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry 23 (1960) 56-62
13. Huber C., Batchelor J.R., Fuchs D., Hausen A., Lang A., Niederwieser D., Reibnegger G., Swetly P., Troppmair J., and Wachter H. Immune response-associated production of neopterin: release from macrophages primarily under control of interferon-gamma. Journal of Experimental Medicine 160 (1984) 310-316
14. Insel T.R., Mueller E.A., Gillin J.C., Siever L.J., and Murphy D.L. Tricyclic response and obsessive-compulsive disorder. Progress in Neuro-Psychopharmacology & Biological Psychiatry 9 (1985) 25-31
15. Jenike M.A. Obsessive compulsive disorder. Comprehensive Psychiatry 24 (1983) 99-115
16. Jenike M.A., Baer L., Brotman A.W., Goff D.C., Minichiello W.E., and Regan N.J. Obsessive-compulsive disorder, depression, and the dexamethasone suppression test. Journal of Clinical Psychopharmacology 7 (1987) 182-184
17. Korte S., Arolt V., Peters M., Weitzsch C., Rothermundt M., and Kirchner H. Increased serum neopterin levels in acutely ill and recovered schizophrenic patients. Schizophrenia Research 32 (1998) 63-67
18. Lieberman J.A., Kane J.M., Sarantakos S., Cole K., Howard A., Borenstein M., Novacenko H., and Puig-Antich J. Dexamethasone suppression tests in patients with obsessive-compulsive disorder. American Journal of Psychiatry 142 (1985) 747-751
19. Maes M., Scharpe S., Meltzer H.Y., Okayli G., Bosmans E., D'Hondt P., Vanden Bossche B.V., and Cosyns P. Increased neopterin and interferon-gamma secretion and lower availability of l-tryptofan in major depression: further evidence for an immune response. Psychiatry Research 54 (1994) 143-160
20. Marks I.M. Are there anticompulsive or antiphobic drugs? Review of the evidence. British Journal of Psychiatry 143 (1983) 338-347
21. Mendelson J.H., Ogata M., and Mello N.K. Adrenal function and alcoholism. I. Serum cortisol. Psychosomatic Medicine 33 (1971) 145-157
22. Monteiro W., Marks I.M., Noshirvani H., and Checkley S. Normal dexamethasone suppression test in obsessive-compulsive disorder. British Journal of Psychiatry 148 (1986) 326-329
23. Nemiah J.C., and Uhde T.W. Obsessive-compulsive disorder. In: Kaplan H.I., and Sadock B.J. (Eds). Comprehensive Textbook of Psychiatry. 5th ed (1989), Williams & Wilkins, Baltimore 984-1000
24. O'Hanlon M., Salter S., Scull D., and Labib M. Neopterin levels in alcohol-dependent patients. Annals of Clinical Biochemistry 33 (1996) 536-539
25. O'Toole S.M., Chiappelli F., and Rubin R.T. Plasma neopterin in major depression: relationship to basal and stimulated pituitary-adrenal cortical axis function. Psychiatry Research 79 (1998) 21-29
26. Stokes P.E. Adrenocortical activation in alcoholics during chronic drinking. Annals of the New York Academy of Sciences 215 (1973) 77-83